US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist

23.060
+1.280+5.88%

Close Feb 28 16:00 ET

22.750
-0.310-1.34%

Post 20:01 ET

406.20MMarket Cap85.41P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rigel Pharmaceuticals Q4 2024 Estimates Date

Currency：USDMar 4, 2025

	Estimate	YoY
Revenue	57.59M	+60.90%
EPS	0.62	--

Analyst Rating

Buy

Mar 1, 2025

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 47.406M	--
Mar 4, 2025	2024/Q4	-- / 57.590M	--
Nov 7, 2024	2024/Q3	55.307M / 41.934M	--
Aug 6, 2024	2024/Q2	36.841M / 33.704M	--
May 7, 2024	2024/Q1	29.534M / 31.472M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 47.406M--

Mar 4, 20252024/Q4-- / 57.590M--

Nov 7, 20242024/Q355.307M / 41.934M--

Aug 6, 20242024/Q236.841M / 33.704M--

May 7, 20242024/Q129.534M / 31.472M--

Unlock Free Earnings Estimates

Open Account

Rigel Pharmaceuticals Earnings Reports

Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7, 2024 16:29 ET

Rigel Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:14 ET

Rigel Pharmaceuticals | 8-K: Press Release, dated August 6, 2024, titled “Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update.”

Aug 6, 2024 16:15 ET

Rigel Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 16:09 ET